Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

TPE/6955 stock hub

TPE/6955 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPE/6955is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.9B

Taiwan Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPE/6955

In the news

Latest news · TPE/6955

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/E38.6

P25 14.4P50 18P75 31.9

ROE16.9

P25 -16.2P50 0.3P75 9.8

ROIC107.1

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPE/6955 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

204

Groups with data

Currency

TWD

Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Enterprise value	TWD 3.4B
Exchange	Taiwan Stock Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Medical Devices
Last refreshed	2026-05-10
Market cap	TWD 3.9B
Price	TWD 159
Price currency	TWD
Sector	Healthcare
Sic	3845
Symbol	tpe/6955
Website	https://bonraybio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.6%
EV Earnings	33.09x
EV/EBIT	33.94x
EV/EBITDA	30.23x
EV/FCF	41.66x
EV/Sales	11.07x
FCF yield	2.06%
P/B ratio	6.15x
P/E ratio	38.59x
P/S ratio	12.87x
PE Ratio3 Y	51.6x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	32.63%
EBITDA Margin	35.57%
FCF margin	26.58%
Gross margin	77.87%
Gross Profit	TWD 238.5M
Gross Profit Growth	36.33%
Gross Profit Growth Q	29.04%
Gross Profit Growth3 Y	43.57%
Net Income	TWD 102.5M
Net Income Growth	49.94%
Net Income Growth Q	26.37%
Net Income Growth3 Y	292.98%
Pretax Margin	34.21%
Profit Margin	33.46%
ROA	9.31
Roa5y	1.64
ROCE	15.49
ROE	16.9
Roe5y	4.95
ROIC	107.1
Roic5y	37.74

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	28.87%
EPS Growth	37.33
EPS Growth Q	18.52
EPS Growth3 Y	267.6
FCF Growth	4.44%
FCF Growth Q	11.99%
FCF Growth3 Y	117.66%
OCF Growth	24.78%
OCF Growth Q	26.67%
OCF Growth3 Y	102.85%
Revenue Growth	37.43x
Revenue Growth Q	30.48x
Revenue Growth3 Y	42.31x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.46
Assets	TWD 719.9M
Cash	TWD 573.2M
Current Assets	TWD 650.8M
Current Liabilities	TWD 74.7M
Debt	TWD 22M
Debt EBITDA	TWD 0.2
Debt Equity	TWD 0.03
Debt FCF	TWD 0.27
Equity	TWD 641.4M
Interest Coverage	757.2
Liabilities	TWD 78.5M
Long Term Assets	TWD 69M
Long Term Liabilities	TWD 3.7M
Net Cash	TWD 551.3M
Net Cash By Market Cap	TWD 13.98
Net Cash Growth	6.52%
Net Debt EBITDA	TWD -5.06
Net Debt Equity	TWD -0.86
Net Debt FCF	TWD -6.77
Tangible Book Value	TWD 617.4M
Tangible Book Value Per Share	TWD 24.9
WACC	4.81

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.71
Inventory Turnover	1.96
Net Working Capital	TWD 21.3M
Quick ratio	8.01
Working Capital	TWD 576.1M
Working Capital Turnover	TWD 0.55

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-9.08%
Dividend Growth	15%
Dividend Growth Years	2%
Dividend per share	TWD 1.5
Dividend Years	3
Dividend Yield	0.94%
Ex Div Date	2026-03-19
Last Dividend	TWD 1.5
Payout Frequency	Annual
Payout Ratio	31.56%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	28.85%
200-day SMA	164.9
50-day SMA	166.4
50-day SMA vs 200-day SMA	50over200
All Time High	187
All Time High Change	-13.88%
All Time High Date	2025-08-07
All Time Low	58.22
All Time Low Change	176.52%
All Time Low Date	2023-07-26
ATR	3.75
Beta	0.11
Beta1y	0.1
Beta2y	0.11
Ch YTD	8.78
High	161
High52	187
High52 Date	2025-08-07
High52ch	-14.95%
Low	159
Low52	127
Low52 Date	2025-05-12
Low52ch	25.24%
Ma50ch	-3.24%
Price vs 200-day SMA	-2.34%
RSI	37.37
RSI Monthly	59.4
RSI Weekly	46.81
Sharpe ratio	0.75x
Sortino ratio	1.41
Total Return	-8.13%
Tr YTD	9.77
Tr1m	-0.62%
Tr1w	-2.72%
Tr3m	-5.82%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 100M
Operating Income Growth	63.99
Operating Income Growth Q	29.96
Operating margin	32.63

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	10,564,278%
Net Borrowing	11,739,000
Shares Insiders	10.17%
Shares Institutions	2.73%
Shares Out	24,801,000
Shares Qo Q	0.63%
Shares Yo Y	9.08%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 81.4M
Average Volume	17,544.9x
Bv Per Share	25.86
CAPEX	TWD -18.6M
Ch1m	-0.62
Ch1w	-2.72
Ch1y	27.69
Ch3m	-6.67
Ch6m	-2.13
Change	-1.24%
Change From Open	-1.24
Close	161
Days Gap	0
Depreciation Amortization	8,997,000
Dollar Volume	2,419,662
Earnings Date	2026-05-13
EBIT	TWD 100M
EBITDA	TWD 108.9M
EPS	TWD 4.12
F Score	3
FCF	TWD 81.4M
FCF EV Yield	2.4x
FCF Per Share	TWD 3.28
Financing CF	-20,610,000
Fiscal Year End	December
Founded	2,015
Graham Number	48.96346
Graham Upside	-69.59
Income Tax	TWD 2.3M
Investing CF	-218,661,000
Is Primary Listing	1
Last Earnings Date	2026-02-26
Last Report Date	2025-12-31
Last Split Date	2025-08-25
Last Split Type	Forward
Lynch Fair Value	TWD 103
Lynch Upside	-36.02
Ma150	165.1
Ma150ch	-2.49%
Ma20	164.4
Ma20ch	-2.07%
Net CF	-138,924,000
Next Earnings Date	2026-05-13
Open	161
P FCF Ratio	48.43
P OCF Ratio	39.44
Payment Date	2026-04-10
Position In Range	0
Ppne	18,387,000
Price Date	2026-05-08
Price EBITDA	TWD 36.19
Ptbv Ratio	6.39
Relative Volume	0.87x
Revenue	306,307,000x
Tax By Revenue	0.74x
Tax Rate	2.17%
Tr6m	-1.24%
Volume	15,218
Z Score	30.25

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPE/6955 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.9%

$1.50 annual per share

Payout ratio

+31.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

2 consecutive years of growth

Total shareholder yield

-8.1%

Next ex-dividend date: 2026-03-19

Performance

TPE/6955 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPE/6955?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.7%

Share of float held by funds and institutions

Insider ownership

+10.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+9.1%

Negative means the company is buying back shares.

Technical

TPE/6955 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.4

Neutral momentum band

Price vs 200-day MA

-2.3%

50/200-day relationship not available

Beta (5Y)

0.11

Less volatile than the market

Sharpe ratio

0.75

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPE/6955

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpe/6955 stock rating?

tpe/6955 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpe/6955 analysis?

The full report lives at /stocks/tpe/6955/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpe/6955?

The latest report frames tpe/6955 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpe/6955 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.